Skip to main content
APM
NASDAQ Industrial Applications And Services

Aptorum Group Files Latest S-4 Amendment for DiamiR Reverse Merger, Details Shareholder Vote on Dilutive Proposals

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.846
Mkt Cap
$6.89M
52W Low
$0.65
52W High
$4.47
52W Position info
30% above low
Off High info
81% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

APM sits 30% above its 52-week low of $0.65.

Summary

Aptorum Group filed its latest S-4 amendment, detailing the upcoming shareholder vote on a reverse merger with DiamiR Biosciences, which includes a reverse stock split and significant dilution for current shareholders, as the company seeks to address its going concern status and maintain its Nasdaq listing.


Key Events · M&A and Partnerships · APM

  • Reverse Merger Update

    This Pre-Effective Amendment No. 4 to the S-4 filing details the proposed reverse merger with DiamiR Biosciences, where DiamiR stockholders will own approximately 70% of the combined company, and existing Aptorum shareholders 30%.

  • Shareholder Vote Scheduled

    A Special Meeting on June 9, 2026, will address proposals including a reverse stock split (at a ratio between 1:2 and 1:10), domestication to Delaware, issuance of shares for the merger, and a new 4.5 million share incentive plan.

  • Guaranteed Approval

    CEO Ian Huen, holding 86.71% of Aptorum's total voting power, has signed an agreement to vote in favor of all proposals, ensuring their approval without the need for other shareholder votes.

  • Going Concern & Nasdaq Compliance

    The company's auditor has expressed substantial doubt about its ability to continue as a going concern, and the proposed reverse stock split is intended to help meet Nasdaq's minimum bid price requirement for continued listing.


Analysis · APM · Industrial Applications And Services

This filing provides the latest comprehensive details for Aptorum Group's proposed reverse merger with DiamiR Biosciences, including critical shareholder proposals for a reverse stock split, domestication to Delaware, and the issuance of shares that will result in existing Aptorum shareholders owning only 30% of the combined entity. The company continues to operate under a going concern warning, making this merger a crucial, albeit highly dilutive, path for its survival and continued Nasdaq listing. The CEO's controlling vote ensures all proposals will pass.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, APM was trading at $0.85 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.9M. The 52-week trading range was $0.65 to $4.47. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

APM - Latest Insights

APM
Jul 20, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.6764
Real-time Price: $0.6764 info
Change: Reverse Stock Split info
Market Cap: $5.701M info
APM
Jul 16, 2026, 11:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.793
Real-time Price: $0.6764 info
Change: Reverse Stock Split info
Market Cap: $5.701M info
APM
Jun 22, 2026, 5:00 PM EDT
Filing Type: 6-K/A
Importance Score:
7
Price at Filing: $0.8581
Real-time Price: $0.6764 info
Change: Reverse Stock Split info
Market Cap: $5.701M info
APM
Jun 22, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.9009
Real-time Price: $0.6764 info
Change: Reverse Stock Split info
Market Cap: $5.701M info
APM
Jun 10, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.19
Real-time Price: $0.6764 info
Change: Reverse Stock Split info
Market Cap: $5.701M info